Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study

Human Reproduction

Volumn 21, Issue 4, 2006, Pages 967-971

  van Dunné, Frederique M ^a   de Craen, A J M ^a   Heijmans, B T ^a   Helmerhorst, F M ^a   Westendorp, R G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Factor V Leiden; Fecundity; Fertility; Pregnancy; Time to pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

AGED; ARTICLE; COHORT ANALYSIS; CONCEPTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY SIZE; FEMALE; FEMALE FERTILITY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; NETHERLANDS; PROGENY; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33645321835     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei422     Document Type: Article

References (25)

1. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA and Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369,64-67.
2. Currie L, Peek M, McNiven M, Prosser I, Mansour J and Ridgway J (2002) Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia? BJOG 109,191-196.
3. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer MF, De Ronde H, Oei SG, Kanhai HH and Rosendaal FR (1999) Preeclampsia and genetic risk factors for thrombosis: A case-control study. Am J Obstet Gynecol 181,975-980.
4. van Dunné FM, Doggen CJ, Heemskerk M, Rosendaal FR and Helmerhorst FM (2005) Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 20,802-806.
5. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P and Freundl G (2003) Time to pregnancy: Results of the German prospective study and impact on the management of infertility. Hum Reprod 18,1959-1966.
6. Göpel W, Ludwig M, Junge AK, Kohlmann T, Diedrich K and Moller J (2001) Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet 358,1238-1239.
7. Heijmans BT, Westendorp RG, Knook DL, Kluft C and Slagboom PE (1998) The risk of mortality and the factor V Leiden mutation in a population-based cohort. Thromb Haemost 80,607-609.
8. Hundsdoerfer P, Vetter B, Stover B, Bassir C, Scholz T, Grimmer I, Monch E, Ziemer S, Rossi R and Kulozik AE (2003) Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss. Thromb Haemost 90,628-635.
9. Joffe M (2000) Time trends in biological fertility in Britain. Lancet 355,1961-1965.
10. Krabbendam I, Franx A, Bots ML, Fijnheer R and Bruinse HW (2005) Thrombophilias and recurrent pregnancy loss: A critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 118,143-153.
11. Leridon H (1977) Human Fertility: The Basic Components. University of Chicago Press, Chicago - London.
12. Lindqvist PG, Zoller B and Dahlback B (2001) Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden - an evolutionary advantage? Thromb Haemost 86,1122-1123.
13. Lissens W and Liebaers I (1997) The genetics of male infertility in relation to cystic fibrosis. Baillieres Clin Obstet Gynaecol 11,797-817.
14. Majerus PW (1994) Human genetics. Bad blood by mutation. Nature 369,14-15.
15. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M and Vickers MA (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: Results from a large population-based study and systematic review. Thromb Haemost 87,779-785.
16. Pauer HU, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G and Neesen J (2003) Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand 82,942-947.
17. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K and Regan L (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16,961-965.
18. Rees DC (1996) The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 95,579-586.
19. Rees DC, Cox M and Clegg JB (1995) World distribution of factor V Leiden. Lancet 346,1133-1134.
20. Rosendaal FR, Koster T, Vandenbroucke JP and Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85,1504-1508.
21. Sallmen M, Weinberg CR, Baird DD, Lindbohm ML and Wilcox AJ (2005) Has human fertility declined over time?: Why we may never know. Epidemiology 16,494-499.
22. Schlembach D, Beinder E, Zingsem J, Wunsiedler U, Beckmann MW and Fischer T (2003) Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci 105,279-285.
23. Van Aken MO, De Craen AJ, Gussekloo J, Moghaddam PH, Vandenbroucke JP, Heijmans BT, Slagboom PE and Westendorp RG (2002) No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: The Leiden 85-plus study. Eur J Clin Invest 32,750-754.
24. Wang X, Chen C, Wang L, Chen D, Guang W and French J (2003) Conception, early pregnancy loss, and time to clinical pregnancy: A population-based prospective study. Fertil Steril 79,577-584.
25. Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11,398-411.